Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-02-12
2000-02-29
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 530300, 530327, A61K 3804, A61K 3810, C07K 700
Patent
active
060309407
ABSTRACT:
Effective urokinase-type plasminogen activator receptor antagonists have sequences selected from the group LNFGQYLWYT, LCFGCYLWYT, LNFGCYLWCT, LNFGQYLnAYT, LNFdSQYLWYT, LCFGCYLWY, LNFdSQYLnAYT, LNFGdCYLWCT, LCFdSCYLWYT, LCFdSCYLnAYT, LNFdSCYLWCT, or active analogs or active portions thereof.
REFERENCES:
patent: 5340833 (1994-08-01), Bridges et al.
patent: 5656726 (1997-08-01), Rosenberg et al.
Bray Andrew
Rosenberg Steven
Spear Kerry L.
Valerio Robert
Blackburn Robert P.
Chiron Corporation
Field Bret
Hutzell Paula K.
Lentini David P.
LandOfFree
Peptide analog inhibitors of urokinase receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide analog inhibitors of urokinase receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide analog inhibitors of urokinase receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-682990